Literature DB >> 27197645

Manipulation of the Host Cell Cytoskeleton by Chlamydia.

Ana T Nogueira1, Antonio T Pedrosa1, Rey A Carabeo2.   

Abstract

Chlamydiae are obligate intracellular pathogens. They undergo a biphasic developmental cycle differentiating between the infectious but metabolically quiescent elementary body and the vegetative, but non-infectious reticulate body. Chlamydia spends a significant portion of its development in the non-infectious stage, demanding an effective strategy of manipulating the host cells to ensure its intracellular survival and replication. A common target of all Chlamydia species studied so far is the host cell cytoskeleton, with past and recent findings revealing crucial roles in invasion, inclusion maintenance, nutrient acquisition, and egress. The molecular details of how Chlamydia co-opts the cytoskeleton is becoming clearer, with bacterial factors and their corresponding host cell targets identified.

Mesh:

Year:  2018        PMID: 27197645     DOI: 10.1007/82_2016_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  3 in total

1.  Epidermal Growth Factor Receptor and Transforming Growth Factor β Signaling Pathways Cooperate To Mediate Chlamydia Pathogenesis.

Authors:  Joseph U Igietseme; James Partin; Zenas George; Yusuf Omosun; Jason Goldstein; Kahaliah Joseph; Debra Ellerson; Francis O Eko; Jan Pohl; Claudiu Bandea; Carolyn M Black
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Toxoplasma gondii Dysregulates Barrier Function and Mechanotransduction Signaling in Human Endothelial Cells.

Authors:  Armond L Franklin-Murray; Sharmila Mallya; Allen Jankeel; Suhas Sureshchandra; Ilhem Messaoudi; Melissa B Lodoen
Journal:  mSphere       Date:  2020-01-29       Impact factor: 4.389

Review 3.  Pathogenic Puppetry: Manipulation of the Host Actin Cytoskeleton by Chlamydia trachomatis.

Authors:  Liam Caven; Rey A Carabeo
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.